{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:17:48Z","timestamp":1787807868248,"version":"build-2784847793"},"reference-count":53,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15AT010395-19"],"award-info":[{"award-number":["1R15AT010395-19"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15AT008733-18"],"award-info":[{"award-number":["1R15AT008733-18"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"award":["1R15AT010395-19"],"award-info":[{"award-number":["1R15AT010395-19"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["1R15AT008733-18"],"award-info":[{"award-number":["1R15AT008733-18"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of metabolic dysfunction-associated steatotic liver disease, affects approximately 3\u20135% of the global population and lacks effective therapies. This study examined the impact of near-thermoneutral housing on MASH progression in mice fed a fast-food diet (FFD) enriched in fat, sucrose, and cholesterol. Male C57BL\/6J mice were housed under standard (22 \u00b0C) or near-thermoneutral (27 \u00b0C) conditions and fed chow or FFD for 20 weeks. Body weight, composition, liver pathology, hepatic gene expression, plasma lipids, and adipose thermogenic and inflammatory markers were assessed. FFD increased body weight, fat mass, and lean mass at both temperatures. Near-thermoneutral housing markedly exacerbated MASH in FFD-fed mice, with increased steatosis, fibrosis, inflammation, and elevated liver enzymes. Hepatic lipogenic and fibrosis-related gene expression was upregulated, alongside higher plasma total cholesterol and very-low-density lipoprotein levels. Near-thermoneutral housing also impaired brown adipose tissue thermogenesis, reducing uncoupling protein 1 and other thermogenic genes, and modestly altered inguinal white adipose tissue inflammation and thermogenic signaling. These findings demonstrate that near-thermoneutral housing accelerates MASH progression, accompanied by increased hepatic lipid accumulation, fibrosis, and inflammation and reduced adipose thermogenic signatures. These findings identify environmental temperature as a critical modifier of MASH pathophysiology and suggest that enhancing adipose thermogenesis may offer therapeutic potential.<\/jats:p>","DOI":"10.3390\/ijms27177621","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:01:07Z","timestamp":1787670067000},"page":"7621","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Housing at 27 \u00b0C, a Near-Thermoneutral Temperature, Exacerbates Metabolic Dysfunction-Associated Steatohepatitis in C57BL\/6J Mice"],"prefix":"10.3390","volume":"27","author":[{"given":"Lei","family":"Hao","sequence":"first","affiliation":[{"name":"Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA"},{"name":"Department of Allied Health, Indiana University of Pennsylvania, Indiana, PA 15705, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5943-0422","authenticated-orcid":false,"given":"Md Shahjalal Hossain","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Zu","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-9942","authenticated-orcid":false,"given":"Shu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA"},{"name":"College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2023.02.034","article-title":"The exposome and liver disease\u2014How environmental factors affect liver health","volume":"79","author":"Barouki","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mej\u00eda-Guzm\u00e1n, J.E., Belmont-Hern\u00e1ndez, R.A., Ch\u00e1vez-Tapia, N.C., Uribe, M., and Nu\u00f1o-L\u00e1mbarri, N. (2025). Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26072959"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: Definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: A practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"Shang","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejim.2024.01.005","article-title":"Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease","volume":"122","author":"Armandi","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"goae029","DOI":"10.1093\/gastro\/goae029","article-title":"Advancements in pharmacological treatment of NAFLD\/MASLD: A focus on metabolic and liver-targeted interventions","volume":"12","author":"Ciardullo","year":"2024","journal-title":"Gastroenterol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rong, L., Zou, J., Ran, W., Qi, X., Chen, Y., Cui, H., and Guo, J. (2022). Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1087260"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcmgh.2019.04.007","article-title":"Metabolic Targets in Nonalcoholic Fatty Liver Disease","volume":"8","author":"Esler","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/d41573-024-00051-1","article-title":"NASH field celebrates \u2018hurrah moment\u2019 with a first FDA drug approval for the liver disease","volume":"23","author":"Kingwell","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/HEP.0000000000001608","article-title":"Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance","volume":"83","author":"Bansal","year":"2026","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Noriega, L., Yang, C.Y., and Wang, C.H. (2023). Brown Fat and Nutrition: Implications for Nutritional Interventions. Nutrients, 15.","DOI":"10.3390\/nu15184072"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrendo.2017.132","article-title":"Targeting thermogenesis in brown fat and muscle to treat obesity and metabolic disease","volume":"14","author":"Betz","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2021.12.016","article-title":"Adipose-tissue plasticity in health and disease","volume":"185","author":"Sakers","year":"2022","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI60433","article-title":"Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans","volume":"122","author":"Ouellet","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","article-title":"An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease","volume":"78","author":"Lee","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/nm.3713","article-title":"The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.molmet.2017.03.016","article-title":"Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders","volume":"6","author":"Chen","year":"2017","journal-title":"Mol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","article-title":"Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human","volume":"150","author":"Wu","year":"2012","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yang, S., Liu, Y., Wu, X., Zhu, R., Sun, Y., Zou, S., Zhang, D., and Yang, X. (2024). Molecular Regulation of Thermogenic Mechanisms in Beige Adipocytes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126303"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bae, Y.A., and Cheon, H.G. (2026). Adipocyte Browning: A Promising Avenue in Anti-Obesity Therapy. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031321"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/cr.2013.64","article-title":"Brown adipose tissue transplantation improves whole-body energy metabolism","volume":"23","author":"Liu","year":"2013","journal-title":"Cell Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1210\/en.2014-1598","article-title":"Brown Adipose Tissue Transplantation Reverses Obesity in Ob\/Ob Mice","volume":"156","author":"Liu","year":"2015","journal-title":"Endocrinology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cell.2013.12.021","article-title":"Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch","volume":"156","author":"Cohen","year":"2014","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2036.2011.04723.x","article-title":"Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans","volume":"34","author":"Yilmaz","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00259-015-3166-7","article-title":"The role of active brown adipose tissue in human metabolism","volume":"43","author":"Ozguven","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Hao, L., Khan, M.S.H., Zu, Y., Liu, J., and Wang, S. (2024). Thermoneutrality Inhibits Thermogenic Markers and Exacerbates Nonalcoholic Fatty Liver Disease in Mice. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158482"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e12799","DOI":"10.14814\/phy2.12799","article-title":"Thermoneutrality decreases thermogenic program and promotes adiposity in high-fat diet-fed mice","volume":"4","author":"Cui","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ijo.2014.187","article-title":"Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL\/6 nude mice","volume":"39","author":"Stemmer","year":"2015","journal-title":"Int. J. Obes."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: A major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lee, D., Chiavaroli, L., Ayoub-Charette, S., Khan, T.A., Zurbau, A., Au-Yeung, F., Cheung, A., Liu, Q., Qi, X., and Ahmed, A. (2022). Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials. Nutrients, 14.","DOI":"10.3390\/nu14142846"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-nutr-062220-025831","article-title":"Dietary Fructose and Fructose-Induced Pathologies","volume":"42","author":"Jung","year":"2022","journal-title":"Annu. Rev. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e209993","DOI":"10.1001\/jamanetworkopen.2020.9993","article-title":"Association of Major Food Sources of Fructose-Containing Sugars With Incident Metabolic Syndrome: A Systematic Review and Meta-analysis","volume":"3","author":"Khan","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_41","first-page":"e74143","article-title":"Dietary Fructose: A Literature Review of Current Evidence and Implications on Metabolic Health","volume":"16","author":"Agarwal","year":"2024","journal-title":"Cureus"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Oates, J.R., Sawada, K., Giles, D.A., Alarcon, P.C., Damen, M., Szabo, S., Stankiewicz, T.E., Moreno-Fernandez, M.E., and Divanovic, S. (2023). Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1095132"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Horakova, O., Sistilli, G., Kalendova, V., Bardova, K., Mitrovic, M., Cajka, T., Irodenko, I., Janovska, P., Lackner, K., and Kopecky, J. (2023). Thermoneutral housing promotes hepatic steatosis in standard diet-fed C57BL\/6N mice, with a less pronounced effect on NAFLD progression upon high-fat feeding. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1205703"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Stojchevski, R., Chandrasekaran, P., Hadzi-Petrushev, N., Mladenov, M., and Avtanski, D. (2024). Adipose Tissue Dysfunction Related to Climate Change and Air Pollution: Understanding the Metabolic Consequences. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147849"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Schirinzi, V., Poli, C., Berteotti, C., and Leone, A. (2023). Browning of Adipocytes: A Potential Therapeutic Approach to Obesity. Nutrients, 15.","DOI":"10.3390\/nu15092229"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2018.11.002","article-title":"New Advances in Adaptive Thermogenesis: UCP1 and Beyond","volume":"29","author":"Chouchani","year":"2019","journal-title":"Cell Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nm.4346","article-title":"Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling","volume":"23","author":"Giles","year":"2017","journal-title":"Nat. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1152\/ajpendo.00124.2023","article-title":"Thermoneutral housing does not accelerate metabolic dysfunction-associated fatty liver disease in male or female C57Bl\/6J mice fed a Western diet","volume":"325","author":"Nunes","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.30652","article-title":"Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress","volume":"73","author":"Cho","year":"2021","journal-title":"Hepatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher\u2019s guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Flessa, C.M., Nasiri-Ansari, N., Kyrou, I., Leca, B.M., Lianou, M., Chatzigeorgiou, A., Kaltsas, G., Kassi, E., and Randeva, H.S. (2022). Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415791"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jconrel.2021.03.022","article-title":"Browning white adipose tissue using adipose stromal cell-targeted resveratrol-loaded nanoparticles for combating obesity","volume":"333","author":"Zu","year":"2021","journal-title":"J. Control. Release"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7621\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:21:39Z","timestamp":1787804499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":53,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177621"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177621","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}